CA1246054A - Synthetic st toxin, process for its preparation and its use as a vaccinating agent - Google Patents
Synthetic st toxin, process for its preparation and its use as a vaccinating agentInfo
- Publication number
- CA1246054A CA1246054A CA000426666A CA426666A CA1246054A CA 1246054 A CA1246054 A CA 1246054A CA 000426666 A CA000426666 A CA 000426666A CA 426666 A CA426666 A CA 426666A CA 1246054 A CA1246054 A CA 1246054A
- Authority
- CA
- Canada
- Prior art keywords
- cys
- asn
- tyr
- gly
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C07K16/1232—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207179A FR2525592B1 (https=) | 1982-04-26 | 1982-04-26 | |
| FR8207179 | 1982-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1246054A true CA1246054A (en) | 1988-12-06 |
Family
ID=9273400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000426666A Expired CA1246054A (en) | 1982-04-26 | 1983-04-25 | Synthetic st toxin, process for its preparation and its use as a vaccinating agent |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4499080A (https=) |
| EP (1) | EP0093652B1 (https=) |
| JP (1) | JPS58201754A (https=) |
| CA (1) | CA1246054A (https=) |
| DE (1) | DE3368387D1 (https=) |
| FR (1) | FR2525592B1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
| US5698201A (en) * | 1973-05-07 | 1997-12-16 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
| US4767842A (en) * | 1973-05-07 | 1988-08-30 | The Ohio State University | Antigenic modification of polypeptides |
| US4762913A (en) * | 1973-05-07 | 1988-08-09 | The Ohio State University | Antigenic modification of polypeptides |
| US6143305A (en) * | 1973-05-07 | 2000-11-07 | The Ohio State University | Antigenically modified polypeptides composition |
| US6039948A (en) * | 1973-05-07 | 2000-03-21 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
| US5006334A (en) * | 1973-05-07 | 1991-04-09 | The Ohio State University | Antigenic modification of polypeptides |
| US6096318A (en) * | 1973-05-07 | 2000-08-01 | The Ohio State University | Antigenically modified HCG polypeptides |
| US4886663A (en) * | 1983-01-03 | 1989-12-12 | Scripps Clinic And Research Foundation | Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof |
| US4575495A (en) * | 1983-05-12 | 1986-03-11 | New York Blood Center, Inc. | Synthetic antigenic peptide derived from Hepatitis B surface antigen |
| US4578217A (en) * | 1983-05-12 | 1986-03-25 | New York Blood Center, Inc. | Synthetic antigenic peptide derived from hepatitis B surface antigen |
| IL69558A (en) * | 1983-08-23 | 1988-06-30 | Yeda Res & Dev | Synthetic cholera vaccine |
| FR2551088B1 (https=) * | 1983-08-29 | 1985-12-06 | Pasteur Institut | |
| US4740585A (en) * | 1984-07-30 | 1988-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Synthetic vaccine against urinary infections |
| US4855285A (en) * | 1985-12-04 | 1989-08-08 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
| US5817753A (en) | 1985-12-04 | 1998-10-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
| US4929718A (en) * | 1987-12-14 | 1990-05-29 | Universidad Nacional Autonoma De Mexico | Synthetic noxiustoxin related peptides |
| US5439792A (en) * | 1989-06-02 | 1995-08-08 | Genetic Systems Corporation | Cysteine thiol-protected peptides for use in immunoassays |
| CA2056381C (en) * | 1989-06-02 | 2000-08-22 | James Blake | Cysteine thiol-protected peptides for use in immunoassays |
| EP0438332B1 (fr) * | 1990-01-16 | 1998-04-08 | Orgenics Ltd. | Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA |
| HU206372B (en) * | 1990-09-03 | 1992-10-28 | Richter Gedeon Vegyeszet | Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same |
| TW227004B (https=) * | 1990-12-19 | 1994-07-21 | Hoechst Ag | |
| JP2955082B2 (ja) * | 1991-10-11 | 1999-10-04 | 大阪瓦斯株式会社 | ヒトカルシトニンのn末端部分を特異的に認識するモノクローナル抗体 |
| US7097839B1 (en) * | 1993-10-26 | 2006-08-29 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| US5879656A (en) * | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| AUPO427596A0 (en) * | 1996-12-20 | 1997-01-23 | Cooperative Research Centre For Tropical Plant Pathology | Anti-microbial protein |
| JP4037933B2 (ja) * | 1996-12-24 | 2008-01-23 | 大阪瓦斯株式会社 | 抗ヒトカルシトニンモノクローナル抗体 |
| US6008378A (en) * | 1997-10-21 | 1999-12-28 | The Regents Of The University Of California | Synthetic molecules that specifically react with target sequences |
| CA2321961A1 (en) | 1998-02-24 | 1999-08-26 | Dovetail Technologies Inc. | Novel disulfides and thiol compounds |
| EP2355846A4 (en) | 2008-09-03 | 2013-06-19 | Univ Michigan State | IMMUNOGENIC HEAT STABILIZER ESCHERICHIA COLI-ENTEROTOXIN |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5836308B2 (ja) * | 1977-02-10 | 1983-08-08 | 大塚製薬株式会社 | 抗体の製造方法 |
| CA1138773A (en) * | 1979-04-18 | 1983-01-04 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
| US4314993A (en) * | 1980-04-04 | 1982-02-09 | Smithkline-Rit | Immunogenic E. coli ST enterotoxin derivatives and compositions containing them |
| US4290944A (en) * | 1980-07-31 | 1981-09-22 | Northwestern University | Antigenic peptide compound |
-
1982
- 1982-04-26 FR FR8207179A patent/FR2525592B1/fr not_active Expired
-
1983
- 1983-04-25 CA CA000426666A patent/CA1246054A/en not_active Expired
- 1983-04-26 US US06/488,712 patent/US4499080A/en not_active Expired - Fee Related
- 1983-04-26 EP EP83400827A patent/EP0093652B1/fr not_active Expired
- 1983-04-26 DE DE8383400827T patent/DE3368387D1/de not_active Expired
- 1983-04-26 JP JP58072336A patent/JPS58201754A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2525592A1 (https=) | 1983-10-28 |
| EP0093652B1 (fr) | 1986-12-17 |
| DE3368387D1 (en) | 1987-01-29 |
| EP0093652A1 (fr) | 1983-11-09 |
| FR2525592B1 (https=) | 1984-09-14 |
| JPS58201754A (ja) | 1983-11-24 |
| US4499080A (en) | 1985-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1246054A (en) | Synthetic st toxin, process for its preparation and its use as a vaccinating agent | |
| Yi-An et al. | Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system | |
| AU667578B2 (en) | Retro-, inverso-, and retro-inverso synthetic peptide analogues | |
| US4886663A (en) | Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof | |
| CA1194794A (en) | Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom | |
| WO1991008220A1 (en) | A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines | |
| US4761470A (en) | Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody | |
| US6455244B1 (en) | Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents | |
| Zauner et al. | Identification of the polypeptide encoded by the URF‐1 gene of Neurospora crassa mtDNA | |
| JP3851761B2 (ja) | Hiv抗体を検出するための合成ペプチド及びその混合物 | |
| CA1271717A (en) | Polypeptides useful in vaccination against enteroviruses | |
| US4596674A (en) | Immunogenic HAV peptides | |
| JPH09500784A (ja) | 非a、非b型肝炎の診断及び検出に有効である直鎖及び分枝鎖ペプチド | |
| US4857634A (en) | Peptides useful in vaccination against enteroviruses | |
| JPS61500664A (ja) | 大腸菌の熱不安定な腸毒素の一部に対応する合成ポリペプチド、その組成物及びそれによる方法 | |
| AU652611B2 (en) | Analogs of piscine LHRH | |
| FI81452C (fi) | Diagnostiskt system foer bestaemning av pilusproteinet av neisseria gonorrhoeae-bakterie. | |
| JPS63264600A (ja) | ウシ白血病ウイルスに対する感染防御抗体を誘導するペプチド分画と、この分画を得る方法と、この分画の遺伝暗号配列と、この分画から製造されるワクチン | |
| IE67533B1 (en) | HIV related peptides | |
| Fischer et al. | Synthetic peptide antigens of tetanus toxin | |
| FR2532850A1 (fr) | Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention | |
| Ota et al. | Characteristics of the epitope of protein-reactive anti-peptide antibodies | |
| Tam et al. | Preparation of site-specific peptide immunogens using multiple antigen peptide approach system | |
| WO1996034884A2 (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use | |
| DE3827416A1 (de) | Peptide mit prourokinase-sequenzen, verfahren zu ihrer herstellung und ihre verwendung, antikoerper gegen diese peptide und mittel enthaltend diese antikoerper zur bestimmung von prourokinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |